Congleton Jon Insider Trading Activity

Average Profitability
24.98%
Insider Buys Quantity
4
Insider Buys Sum
$105,540.93
Insider Sells Quantity
10
Insider Sells Sum
$2.29M

Insider Activity of Congleton Jon

According to the SEC Form 4 filings, Congleton Jon, being in a position of

  1. Chief Executive Officer at Mineralys Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 542213 shares for $18.13M,
    over all time since 2023-08-11, has bought 10750 shares for $105,541, and sold 773524 shares for $21.87M.

Biography of Congleton Jon

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $18,130,6158100

Comparison of Insiders on Amount of Buys and Sells

2026-09-30SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
75,000
0.0862%
$25.46$1.91M-15.2%
2026-07-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
10,700
0.0159%
$27.24$291,441-5.51%
2026-06-30SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
75,000
0.11%
$26.14$1.96M-2.06%
2026-04-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,730
0.0234%
$26.83$421,979-1.4%
2026-03-31SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
75,000
0.1097%
$26.27$1.97M-0.81%
2026-03-31SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
74,547
0.109%
$26.27$1.96M-0.81%
2026-01-12SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
16,236
0.0242%
$32.62$529,640-17.94%
2025-11-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
200,000
0.3606%
$45.44$9.09M-41.22%
2025-10-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,100
0.0226%
$42.67$644,327-33.96%
2025-10-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
13,548
0.0202%
$42.63$577,544-33.96%
2025-07-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,884
0.0244%
$14.51$230,431+105.31%
2025-04-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,319
0.0247%
$12.19$186,803+109.4%
2025-01-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
18,333
0.0359%
$9.06$166,082+63.68%
2024-10-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,271
0.0325%
$13.52$206,433+1.62%
2024-07-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,746
0.0331%
$13.34$210,075-3.61%
2024-06-20SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
14,940
0.0276%
$11.73$175,237+9.31%
2024-06-18SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
16,607
0.0313%
$11.99$199,073+8.44%
2024-06-17SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
17,766
0.0343%
$12.25$217,712+4.59%
2024-06-14SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
16,229
0.032%
$12.52$203,163+0.95%
2024-06-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
39,961
0.0801%
$12.74$509,027-0.2%
Total: 25
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.